期刊文献+

联合使用干细胞因子、FLT3配基与白介素2,7,15体外扩增人脐血来源CIK/NK细胞 被引量:17

Expansion of CIK/NK Cells from Cord Blood by Using Different Combinations of Stem Cell Factor,FLT3 Ligand and Interleukin 2,7,15 in vitro
下载PDF
导出
摘要 通过干细胞因子 (SCF)、FLT3配基 (FL)联合白介素 (IL) 2 ,7,15等的不同组合体系体外扩增人脐血来源的CIK NK细胞 (CB CIK NK) ,探讨不同培养方式对CB CIK NK细胞诱导、扩增产率的影响。按诱导扩增体系的不同分 3组 :A组 (SCF +IL2 +IL7+IL15 ) ,B组 (SCF +FL +IL2 +IL7+IL15 )和C组 (IL2 +IL7+IL15 ,对照组 ) ,培养 2 1天 ,检测CD3+ CD5 6 + CIK细胞、CD3- CD5 6 + NK细胞比例和扩增倍数。结果表明 :经 2 1天培养 ,A ,B及C组CIK细胞比例分别为 (19.84± 2 .93) %、(2 6 .2 0± 4 .0 5 ) %及 (2 4 .0 3± 4 .99) % ;而NK细胞的比例A、B及C组比例分别为 (4 9.6 0± 1.4 0 ) %、(5 1.16± 6 .4 5 ) %及 (30 .85± 8.12 ) %。含SCF +FL的B组扩增效率最高 ,其中CIK细胞的扩增倍数由对照组 (C组 )的 (5 75 81± 2 2 1.72 )倍增加至 (796 .0 9± 2 78.4 7)倍 (最高为 1313倍 ) ;NK细胞由对照组 (C组 )的 (30 .39± 14 .4 7)倍增加至 (6 5 .85± 30 .83)倍 (最高为 12 1.0 6倍 )。结论 :通过合适的细胞因子组合可以同时扩增CB来源的CIK NK细胞 ;联合诱导、扩增CB CIK NK细胞以采用含SCF +FL +IL2 +IL7+IL15的培养体系为佳。 To explore the efficacy of the different combinations of stem cell factor (SCF),FLT3 ligand(FL)and interleukin (IL)2,7 ,15 on the induction and expansion of cord blood (CB) derived CIK/ NK cells in vitro,according to the different combinations of cytokines,combinations of cytokines were divided into 3 groups: group A (SCF+IL2+IL7+IL15),group B (SCF+FL+IL2+IL7+IL15) and group C (IL2+IL7+IL15 as control group). At 21 days of culture,the proportion and the expansion rate of CD3+CD56+ CIK cells and CD3-CD56+ NK cells were measured. The results showed that at 21 days in culture,the percentages of CD3+CD56+ CIK cells derived from CB-MNC in group A,B and C were (19.84±2.93)%,(26.20±4.05)%,(24.03±4.99%) and that of NK cells were (49.60±1.40)%,(51.16±6.45)% and (30.85±8 12)%,respectively. The proliferation of CD3+CD56+ CIK cells and CD3-CD56+ NK cells was the most effective in group B (SCF+FL+IL2+IL7+IL15). Expansion multiple of CIK cell number increased from 575.81±221.72 (control) to 796.09±278.47 with peak value of 1 313 ,and that of NK cells increased from 30.39±14.47 (control) to 65.85±30.83 with peak value of 121.06. In conclusion,a proper cytokines (SCF+FL+IL2+IL7+IL15) culture system can effectively induce and expand CB CD3+CD56+ CIK cells and CD3-CD56+ NK cells simultaneously.
出处 《中国实验血液学杂志》 CAS CSCD 2004年第3期350-354,共5页 Journal of Experimental Hematology
基金 2 0 0 3年广东省自然科学基金资助项目 编号 0 3 170 7
关键词 CIK/NK细胞 脐血 干细胞因子 FLT3配基 白介素2 白介素7 白介素15 CIK/NK cell cord blood stem cell factor FLT3 ligand IL-2 IL-7 IL-15
  • 相关文献

参考文献4

二级参考文献22

  • 1朱慧芬,张悦,王晓林,邵静芳,沈关心.MTT比色法检测IL-2和杀伤细胞活性的研究[J].免疫学杂志,1994,10(1):48-51. 被引量:55
  • 2陈毓仙,石卫,万云霞,陈金栋,李艳芬,翟红.可溶性肿瘤抗原和CD3单克隆抗体共同诱导的杀瘤细胞——T-AK细胞[J].中华微生物学和免疫学杂志,1995,15(5):293-296. 被引量:19
  • 3[1]Rosenberg SA , Lotze MT. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes[J]. Annu Rev Immunol, 1986,4:681-709.
  • 4[2]Oliver A, Canton L, Montanar M, et al. GM-CSF plus IL-2 administration associated with multiple autologous LAK reinfusion can induce a major cytogenetic response in early relapsed CML after autologous transplantation:a case report [J]. Bone Marrow Transplantation, 1998,21(1):65-69.
  • 5[3]Ridolfi R, Flamini E, Riccobon A, et al. Adjuvant adoptive immunotherapy with tumor-infiltrating lymphocytes and modulated doses of IL-2 in 22 patients with melanoma, colorectal and renal cancer, after radical matastectomy, and in 12 advanced pa-tients[J]. Cancer Immunol Immunother, 1998,46(4):185-193.
  • 6[4]Schmidt Wolf IG, Negrin RS,Kiem HP, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J]. J Exp Med, 1991,174(1):139-149.
  • 7[5]Schmidt Wolf IG, Finke S,Trojaneck B,et al. Phase Ⅰ clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma[J]. Br J Cancer, 1999,81(6):1 009-1 016.
  • 8[1]Lu PH, Negrin RS. A novel population of expanded human CD3 + CD56 + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1994, 153(4): 1687-1696.
  • 9[2]Schmidt-Wolf GD, Negrin RS, Schmidt-Wolf IG. Activated T cells and cytokine-induced CD3 + CD56 + killer cells [ J ]. Ann Hematol, 1997, 74(2): 51-56.
  • 10[3]Hoyle C, Bangs CD, Negrin RS, et al. Expansion of philadelphia chromosome-negative CD3 + CD56 + cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice [ J ]. Blood, 1998, 92(9): 3318-3327.

共引文献65

同被引文献175

引证文献17

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部